Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Namisol in chronic pancreatitis pain
NL-OMON37765Phase 2Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sodium oxybate in chronic pancreatitis (CP) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: VAS average pain change from baseline to days 50-52. Started Oct 2012; status: active, not recruiting.
02
Drugs
sodium oxybate
03
Conditions
chronic pancreatitis (CP)
Beyond the preview
Go deeper on NL-OMON37765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37765.